tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Tianjin Pharmaceutical Da Ren Tang Group Updates Articles of Association

Story Highlights
  • Tianjin Pharmaceutical Da Ren Tang Group announces amendments to its Articles of Association.
  • The company plans to abolish its Supervisory Committee, transferring functions to the Audit Committee.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Tianjin Pharmaceutical Da Ren Tang Group Updates Articles of Association

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ) has shared an update.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhongxin Pharmaceutical Group Corporation Limited, has announced amendments to its Articles of Association. These changes are in response to the updated Company Law of the People’s Republic of China and the revised guidelines from the China Securities Regulatory Commission. The company proposes to abolish its Supervisory Committee and transfer its functions to the Audit Committee, aligning with new regulatory requirements and addressing its management needs.

More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S

Learn more about 2TZ stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1